Search Results 171-180 of 19050 for creatinine

1. Long-term Safety And Effectiveness Study For Participants With Advanced Tumors Who Are Currently On Treatment Or In Follow-up In A Pembrolizumab Trial - Mayo Clinic

   Renal. Creatinine OR. Measured or calculatedb creatinine clearance | ≤ 1.5 × ULN OR. (GFR can also be used in place of creatinine or CrCl) | ≥ 30 mL/min for ...

2. Anetumab Ravtansine And Atezolizumab In Treating Participants With Advanced Non-small Cell Lung Cancer - Mayo Clinic

   NOTE: Supplementation may be given before the first dose of study medication. INR ≤ 1.5; Serum creatinine ≤1.5mg/dL or creatinine clearance ≥50 mL/min ( ...

3. A Study Of Pembrolizumab (MK-3475) Versus Placebo In Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy In The Treatment Of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer - Mayo Clinic

   Hemoglobin* ≥ 9 g/dL or ≥ 5.6 mmol/L. Renal. Creatinine ≤ 1.5 × ULN; OR; Measured or calculated** creatinine clearance (GFR can also be used instead of ...

4. Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant - Mayo Clinic

   Participation eligibility · Creatinine clearance for males = (140 - age)(actual body weight in kg)/ (72)(serum creatinine in mg/dL); · Creatinine clearance for ...

5. Vinorelbine Tartrate and Cyclophosphamide in Combination with Bevacizumab or Temsirolimus in Treating Patients with Recurrent or Refractory Rhabdomyosarcoma - Mayo Clinic

   Creatinine clearance or radioisotope glomerular filtration rate (GFR) ≥ 70 mL/min/1.73 m^2 OR a serum creatinine based on age/gender as follows: ≤ 0.4 mg ...

6. Pediatric white blood cell disorders - Symptoms and causes - Mayo Clinic

   Eosinophils. Eosinophilia (e-o-sin-o-FIL-e-uh) is a having too many eosinophil cells. These cells help with swelling and irritation, called inflammation. They ...

7. Evaluation Of The Efficacy And Safety Of Magnetic Resonance Angiography (MRA) Using Gadopiclenol Compared To Gadoterate Meglumine In The Assessment Of Steno-occlusive Disease In Adult Patients With Suspected Vascular Disease - Mayo Clinic

   Increase in serum creatinine by ≥ 0.3 mg/dL (≥ 26.5 μmol/L) within 48 hours or b. Increase in serum creatinine to ≥ 1.5 times baseline, which is known or ...

8. A Study of Changes in Renal Biomarkers after Exposure to Contrast Associated with CT scan - Mayo Clinic

   ... creatinine above the reference range (at least 1.3 mg/dL for males, 1/1 mg/dL for females). Exclusion Criteria: Patients who have a pre-existing renal ...

9. A Study To Evaluate The Safety And Effectiveness Of Pembrolizumab Compared To Placebo In Resected High-risk Stage II Melanoma Patients - Mayo Clinic

   Renal. Creatinine OR Measured or calculated2 creatinine clearance (GFR can also be used in place of creatinine or CrCl) | ≤ 1.5 × ULN OR ≥ 0 mL/min for ...

10. Study Of Pembrolizumab Combined With Decitabine And Pralatrexate In Peripheral T-cell Lymphoma And Cutaneous T-cell Lymphoma - Mayo Clinic

    Participation eligibility · Serum creatinine OR Measured or calculated* creatinine clearance. GFR can also be used in place of creatinine or CrCl · *Creatinine ...